XERS- Xeris Biopharma Holdings, Inc.

Name: Xeris Biopharma Holdings, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Xeris Biopharma Holdings, Inc. (XERS) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. XERS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shannon John Patrick Jr	3.05M	$21.02M	-
Other	McCulloch Kevin	1.79M	$12.32M	-
Other	Pieper Steven	1.46M	$10.08M	-
Other	Hecht Beth	1.18M	$8.12M	-16,667
Dir	Johnson John	698.1K	$4.82M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 11, 2025	Hecht Beth47	See Remarks	Sell	16,667	$7.40	$123,295.80	-1.2%	-6.5%	-
Sep 11, 2025	Persky Marla	Director	Sell	15,500	$7.72	$119,610.40	-9.8%	-9.6%	-
Aug 28, 2025	Sherman Jeffrey W	Director	Sale+OE	42,232	$7.92	$334,515.45	-16.2%	-9.1%	-
Aug 13, 2025	Johnson John	Director	Sell	107,500	$7.32	$786,459.25	-11.4%	+2.2%	-
Aug 12, 2025	Halkuff Dawn	Director	Sell	42,500	$7.28	$309,225.75	-27.0%	+5.8%	-
Jun 13, 2025	McCulloch Kevin	See Remarks	Buy	25,000	$4.38	$109,475.00	+1.5%	+76.6%	+56.1%
Mar 20, 2025	Hecht Beth47	See Remarks	Sell	40,000	$5.43	$217,244.00	-2.9%	-15.7%	+0.2%
Aug 12, 2024	Schmid John P.80	Director	Buy	4,515	$2.25	$10,147.01	+21.8%	+45.8%	+224.4%
Aug 9, 2024	Schmid John P.80	Director	Buy	4,285	$2.37	$10,134.03	+26.1%	+44.8%	+194.8%
May 10, 2024	Schmid John P.80	Director	Buy	5,400	$1.91	$10,314.00	+49.1%	+26.7%	+184.7%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC